September 2019

SEKISUI XenoTech Named a 2019 Top-Performing Provider on Science Exchange

Author:  Michael Millhollen
Posted:  04 September 2019

Science Exchange stated, "Discovery research programs at growing biotech companies are demanding—R&D leaders must balance the need to innovate with the risk of early technology adoption and the pressure to deliver results quickly. But, with over 10,000 CROs out there, it can be challenging to find trustworthy, relevant reviews of R&D services and providers—this challenge drives thousands of scientists every day to use Science Exchange’s marketplace of 3,000+ prequalified, fully contracted providers."

Science Exchange surveyed these scientists on the challenges they face and compiled a list of top-performing, trending providers in the most requested service categories based on responsiveness, productivity, and requester endorsements. SEKISUI XenoTech ranked in the top 5 providers for Pharmacology services, not just because of our binding and inhibition assays but for our full suite of in vitro and in vivo ADME/PK & DDI services.

We take great pride in the service, quality and expertise that we provide our customers, and are deeply gratified to hear about the feedback that Science Exchange has received about us. Learn more about our research services and test systems and let us know how we can assist your drug development efforts.

Blog post currently doesn't have any comments.
Give Feedback